SOL-GEL TECHNOLOGIES LTD SLGL

US Healthcare Pharmaceutical Preparations
$74.01
+2.8%
52w: $7.01 – $97.97

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
7.0152.4997.97
Jun 20, 2025 Jul 2, 2026
Institutional holders
21
+7 QoQ
13F value
$100.0M
+230.9% QoQ
Smart-money holders
8
signal tier ≥ 2
New smart buyers
5
Q1 2026
Options barometer
calls only
$11K calls / — puts

Institutional value by quarter

$14.9M
Q1 2024
$6.6M
Q2 2024
$3.7M
Q3 2024
$4.9M
Q4 2024
$2.8M
Q1 2025
$4.9M
Q2 2025
$16.3M
Q3 2025
$30.2M
Q4 2025
$100.0M
Q1 2026

Number of holders

21
Q1 2024
21
Q2 2024
21
Q3 2024
18
Q4 2024
22
Q1 2025
12
Q2 2025
10
Q3 2025
14
Q4 2025
21
Q1 2026

Who owns SLGL?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Opaleye Management Inc. ★2Fundamental concentrated500.0K$39.6M5.2%+10.2%
GREAT POINT PARTNERS LLC ★2Fundamental concentrated274.4K$21.7M5.3%New
Phoenix Financial Ltd. Other210.8K$16.7M0.2%-3.4%
Trails Edge Capital Partners, LP ★2Fundamental concentrated85.5K$6.8M1.6%New
CITADEL ADVISORS LLC Multistrat pod37.1K$2.9M0.0%+499.2%
Affinity Asset Advisors, LLC ★2Fundamental diversified35.0K$2.8M0.2%New
Squadron Capital Management LLC ★2Fundamental concentrated31.0K$2.5M1.0%New
Stonepine Capital Management, LLC ★2Fundamental concentrated27.8K$2.2M1.9%New
Yelin Lapidot Holdings Management Ltd. ★2Fundamental diversified17.8K$1.4M0.3%Held
XTX Topco Ltd Market maker8.0K$635K0.0%New
MENORA MIVTACHIM HOLDINGS LTD. ★2Fundamental diversified7.6K$603K0.0%Held
JANE STREET GROUP, LLC Market maker7.2K$567K0.0%New
RAYMOND JAMES FINANCIAL INC Bank broker5.7K$454K0.0%0.0%
MORGAN STANLEY Bank broker5.2K$410K0.0%+10.4%
LPL Financial LLC Bank broker3.5K$275K0.0%New
HRT FINANCIAL LP Diversified mechanical3.2K$254K0.0%New
BlackRock, Inc. Index provider953$75K0.0%Held
UBS Group AG Bank broker694$55K0.0%-45.5%
ROYAL BANK OF CANADA Bank broker276$22K0.0%+89.0%
SBI Securities Co., Ltd. Diversified mechanical72$6K0.0%Held
Allworth Financial LP Wealth advisor5$3970.0%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.